Q1 2025 Earnings Call Transcript April 22, 2025 Danaher Corporation beats earnings expectations. Reported EPS is $1.88, ...

Hyderabad's CSIR institutions drive scientific innovation, drug discovery, and entrepreneurship, contributing to India's self-reliant knowledge economy.

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That same mRNA-powered approach to medicine—in which synthetic mRNA is ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That same mRNA-powered approach to medicine—in which synthetic mRNA is ...

Dublin, April 15, 2025 (GLOBE NEWSWIRE) -- The "MRNA Synthesis & Manufacturing Market by Product (Consumables [Transcription, Purification, Analysis ...

Messenger Ribonucleic Acid (mRNA) vaccines gained global recognition during the Coronavirus Disease 2019 (COVID-19) pandemic, proving their value through rapid development, high efficacy ...

causing changes in gene expression without changing the DNA sequence itself. Thus, vaccination with mRNA vaccines could lead to an enhanced immune response to future encounters with pathogens ...

IMUNON chose a DNA-based approach for COVID-19 because it builds on our expertise in DNA therapeutics and offers distinct advantages over mRNA and traditional vaccines. We saw an opportunity to create ...

The team showed that these DNA-LNPs demonstrate a unique way of priming the immune system compared to mRNA and protein-in-adjuvant formulations. The DNA-LNP induced a unique activation pattern of ...

This shift is expected to bolster the company’s position in the genetic medicines market, particularly for mRNA/DNA products and cell and gene therapies. The company’s strategic moves come at ...